Related Experiment Video
Updated: Jul 7, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Sentinel lymph nodes in breast cancer after 10 years: rethinking basic principles
1Department of Pathology, Box 1194, Mount Sinai Medical Center, 1 Gustave L Levy Place, New York, NY 10029, USA. I.Bleiweiss@mountsinai.org
The Lancet. Oncology
|August 5, 2006
Summary
Sentinel lymph node identification in breast cancer, while widely accepted, has seen overuse and overinterpretation. Further discussion is needed on its application in other organ systems, considering lessons learned from breast cancer experience.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Sentinel lymph node biopsy (SLNB) is a standard oncologic procedure.
- The technique's application has expanded beyond breast cancer.
- Overinterpretation and overuse of SLNB have been noted.
Purpose of the Study:
- To review the fundamental principles of sentinel lymph node identification.
- To discuss the breast cancer experience with SLNB over the past decade.
- To address ongoing controversies and guide future applications.
Main Methods:
- Review of existing literature on SLNB in breast cancer.
- Analysis of theoretical underpinnings of the technique.
- Comparative assessment of SLNB application across different organ systems.
Main Results:
- SLNB in breast cancer has a well-established track record but requires nuanced interpretation.
- Lessons learned from breast cancer SLNB may not directly translate to other sites.
- Further research is needed to optimize SLNB in non-breast applications.
Conclusions:
- Revisiting the core concepts of SLNB is crucial for resolving current debates.
- Careful consideration of technique-specific factors is essential for appropriate application.
- Standardizing SLNB protocols across diverse oncologic settings remains a challenge.
